CCO Oncology Podcast

The Art of Medicine: Clinical Considerations for Patients With Advanced RCC

Episode Summary

Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss clinical management pearls for IO-based therapy in patients with renal cell carcinoma.

Episode Notes

In this episode, an expert medical oncology panel led by Elizabeth R. Plimack, MD, MS, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses clinical pearls for the management of patients with metastatic renal cell carcinoma (RCC). Topics include:

• Treating beyond progression with immunotherapy
• Management of patients with less common histologic subtypes of RCC
• Potential biomarkers for RCC
• Adverse event management

Presenters:

Elizabeth R. Plimack, MD, MS
Chief, Division of Genitourinary Medical Oncology 
Director, Genitourinary Clinical Research 
Professor, Department of Hematology/
Oncology 
Fox Chase Cancer Center 
Temple Health 
Philadelphia, Pennsylvania

Brian A. Costello, MD
Associate Professor of Oncology and Urology
Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota

Martin H. Voss, MD
Clinical Director, Genitourinary Medical Oncology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor 
Weill Cornell Medical College
New York, New York

Content based on an online CME program supported by educational grants from Eisai, Exelixis, and Pfizer and EMD Serono.

Link to full program:
https://bit.ly/32IS9gx